Log in

High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Transplantation-associated thrombotic microangiopathy (TMA) is one of the main complications after hematopoietic stem cell transplantation (HSCT). At the time of onset of gut TMA, a patient developed a high titer of an inhibitor of the non—immunoglobulin G type to ADAMTS13, which physiologically hydrolyzes von Willebrand factor to control spontaneous intravascular thrombus formation.The patient developed symptoms of myositis, a disorder that has occasionally been reported to manifest after HSCT and to resemble some idiopathic autoimmune diseases. However, a muscle biopsy specimen presented pathologic findings of TMA, including microvascular platelet thrombus formation, without inflammatory lymphocyte infiltration. ADAMTS13 activities returned to normal after steroid treatment, and the improvement of TMA symptoms followed. This patient appears to represent a rare case of post-HSCT TMA associated with the development of an ADAMTS13 inhibitor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant. 1994;14:495–504.

    PubMed  CAS  Google Scholar 

  2. Busca A, Uderzo C. BMT: bone marrow transplant associated thrombotic microangiopathy. Hematology. 2000;5:53–67.

    Article  PubMed  Google Scholar 

  3. Selby DM, Rudzki JR, Bayever ES, Chandra RS. Vasculopathy of small muscular arteries in pediatric patients after bone marrow transplantation. Hum Pathol. 1999;30:734–740.

    Article  CAS  PubMed  Google Scholar 

  4. Hirabayashi N. Thrombotic microangiopathy (TMA), 1: TMA in the target organs of graft-versus-host disease [in Japanese]. Rinsho Ketsueki. 2000;41:491–495.

    PubMed  CAS  Google Scholar 

  5. Nishida T, Hamaguchi M, Hirabayashi N, et al. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease. Bone Marrow Transplant. 2004;33:1143–1150.

    Article  CAS  PubMed  Google Scholar 

  6. Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med. 1998;339:1578–1584.

    Article  CAS  PubMed  Google Scholar 

  7. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998;339:1585–1594.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Sadler JE, Moake JL, Miyata T, George JN. Recent advances in thrombotic thrombocytopenic purpura. Hematology (Am Soc Hematol Educ Program). 2004:407–423.

    Article  Google Scholar 

  9. van der Plas RM, Schiphorst ME, Huizinga EG, et al. von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura. Blood. 1999;93:3798–3802.

    PubMed  Google Scholar 

  10. Fujimura Y, Matsumoto M, Yagi H, Yoshioka A, Matsui T, Titani K. von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome. Int J Hematol. 2002;75:25–34.

    Article  CAS  PubMed  Google Scholar 

  11. Kato S, Matsumoto M, Matsuyama T, Hiura H, Fujimura Y. Monoclonal antibodies to a VWF-A2 decapeptide with the C-terminal residue Tyr1605, generated by ADAMTS13 cleavage, develop a highly sensitive ELISA for its activity and characterize Upshaw-Schulman syndrome [abstract]. Blood. 2005;106:742a. Abstract 2643.

    Google Scholar 

  12. Kokame K, Matsumoto M, Fujimura Y, Miyata T. VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13. Blood. 2004;103:607–612.

    Article  CAS  PubMed  Google Scholar 

  13. Nelson KR, McQuillen MP. Neurologic complications of graft-versus-host disease. Neurol Clin. 1988;6:389–403.

    Article  CAS  PubMed  Google Scholar 

  14. Collins PW, Gutteridge CN, O’Driscoll A, et al. von Willebrand factor as a marker of endothelial cell activation following BMT. Bone Marrow Transplant. 1992;10:499–506.

    PubMed  CAS  Google Scholar 

  15. Pham PT, Danovitch GM, Wilkinson AH, et al. Inhibitors of ADAMTS13: a potential factor in the cause of thrombotic microangiopathy in a renal allograft recipient. Transplantation. 2002;74:1077–1080.

    Article  CAS  PubMed  Google Scholar 

  16. Nakazawa Y, Hashikura Y, Urata K, et al. von Willebrand factor—cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation: a case report. Liver Transpl. 2003;9:1328–1333.

    Article  PubMed  Google Scholar 

  17. Kierdorf H, Maurin N, Heintz B. Cyclosporine for thrombotic thrombocytopenic purpura. Ann Intern Med. 1993;118:987–988.

    Article  CAS  PubMed  Google Scholar 

  18. Matsumoto M, Kokame K, Soejima K, et al. Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome. Blood. 2004;103:1305–1310.

    Article  CAS  PubMed  Google Scholar 

  19. Motto DG, Chauhan AK, Zhu G, et al. Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. J Clin Invest. 2005;115:2752–2761.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Stevens AM, Sullivan KM, Nelson JL. Polymyositis as a manifestation of chronic graft-versus-host disease. Rheumatology (Oxford). 2003;42:34–39.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tadashi Matsushita.

About this article

Cite this article

Adachi, T., Matsushita, T., Ichihashi, R. et al. High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation. Int J Hematol 83, 415–419 (2006). https://doi.org/10.1532/IJH97.05157

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1532/IJH97.05157

Key words

Navigation